1) Ushijima K : Management of retroperitoneal lymph nodes in the treatment of ovarian cancer. Int J Clin Oncol 12 : 181─186, 2007
2) 上皮性卵巣腫瘍.卵巣がん治療ガイドライン2007年版(改訂版)(日本婦人科腫瘍学会ed),pp23─26,金原出版,東京,2007
3) Hirahatake K, Hareyama H, Sakuragi N, et al : A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. Journal of Surgical Oncology 65 : 82─87, 1997
4) Morrow CP, Bundy BN, Kurman RJ, et al : Relationship between surgical─pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium : A gynecologic oncology group study. Gynecologic Oncology 40 : 55─65, 1991
5) Marana HR, de Andrade JM, Dos Reis FJ, et al : Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy. J Surg Oncol 100 : 505─510, 2009
6) Sakuragi N : Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol 12 : 165─175, 2007
7) Lee YN, Wang KL, Lin MH, et al : Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer : a clinical review of 954 cases. Gynecol Oncol 32 : 135─142, 1989
8) Creasman WT, Morrow CP, Bundy BN, et al : Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl) : 2035─2041, 1987
9) Morrow CP, Bundy BN, Kurman RJ, et al : Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium : a Gynecologic Oncology Group study. Gynecol Oncol 40 : 55─65, 1991
10) Morice P, Joulie F, Camatte S, et al : Lymph node involvement in epithelial ovarian cancer : analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 197 : 198─205, 2003
11) Chan JK, Urban R, Cheung MK, et al : Lymphadenectomy in endometrioid uterine cancer staging : how many lymph nodes are enough? A study of 11,443 patients. Cancer 109 : 2454─2460, 2007
12) 初回治療.子宮体癌治療ガイドライン2006年版(日本婦人科腫瘍学会,編),pp25─29,金原出版,東京,2006
13) Ib期とII期.子宮頸癌治療ガイドライン2007年版(日本婦人科腫瘍学会ed),pp38─39,金原出版,東京,2007
14) Choi SH, Kim SH, Choi HJ, et al : Preoperative magnetic resonance imaging staging of uterine cervical carcinoma : results of prospective study. J Comput Assist Tomogr 28 : 620─627, 2004
15) Bellomi M, Bonomo G, Landoni F, et al : Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma. Eur Radiol 15 : 2469─2474, 2005
16) Choi EK, Kim JK, Choi HJ, et al : Node-by-node correlation between MR and PET/CT in patients with uterine cervical cancer : diffusion-weighted imaging versus size-based criteria on T2WI. Eur Radiol 19 : 2024─2032, 2009
17) Hricak H, Gatsonis C, Chi DS, et al : Role of Imaging in Pretreatment Evaluation of Early Invasive Cervical Cancer : Results of the Intergroup Study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 23 : 9329─9337, 2005
18) Bipat S, Glas AS, van der Velden J, et al : Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma : a systematic review. Gynecol Oncol 91 : 59─66, 2003
19) Sironi S, Buda A, Picchio M, et al : Lymph node metastasis in patients with clinical early-stage cervical cancer : detection with integrated FDG PET/CT. Radiology 238 : 272─279, 2006
20) Wright JD, Dehdashti F, Herzog TJ, et al : Preoperative lymph node staging of early-stage cervical carcinoma by[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 104 : 2484─2491, 2005
21) Kitajima K, Murakami K, Yamasaki E, et al : Accuracy of integrated FDG─PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur Radiol 19 : 1529─1536, 2009
22) Zerbe MJ, Bristow R, Grumbine FC, et al : Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer. Gynecol Oncol 78 : 67─70, 2000
23) Selman TJ, Mann CH, Zamora J, et al : A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health 8 : 8, 2008
24) Tempany CM, Zou KH, Silverman SG, et al : Staging of advanced ovarian cancer : comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group. Radiology 215 : 761─767, 2000
25) Nam EJ, Yun MJ, Oh YT, et al : Diagnosis and staging of primary ovarian cancer : Correlation between PET/CT, Doppler US, and CT or MRI. Gynecol Oncol, 2009
26) Yang WT, Lam WW, Yu MY, et al : Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 175 : 759─766, 2000
27) Selman TJ, Mann C, Zamora J, et al : Diagnostic accuracy of tests for lymph node status in primary cervical cancer : a systematic review and meta-analysis. CMAJ 178 : 855─862, 2008
28) Nakai G, Matsuki M, Inada Y, et al : Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 32 : 764─768, 2008
29) Hricak H : MRI of the Pelvis : A text atlas. ed), pp43─92, Martin Dunitz, London, 1991
30) 荒木 力 : 拡散MRI. 秀潤社,東京,2006
31) Kim JK, Kim KA, Park BW, et al : Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes : early experience. J Magn Reson Imaging 28 : 714─719, 2008
32) Lin G, Ho KC, Wang JJ, et al : Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 28 : 128─135, 2008
33) Chou HH, Chang TC, Yen TC, et al : Low value of[18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol 24 : 123─128, 2006
34) Chung HH, Park NH, Kim JW, et al : Role of integrated PET─CT in pelvic lymph node staging of cervical cancer before radical hysterectomy. Gynecol Obstet Invest 67 : 61─66, 2009
35) Magne N, Chargari C, Vicenzi L, et al : New trends in the evaluation and treatment of cervix cancer : the role of FDG─PET. Cancer Treat Rev 34 : 671─681, 2008
36) Will O, Purkayastha S, Chan C, et al : Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases : a meta-analysis. Lancet Oncol 7 : 52─60, 2006
37) Harisinghani MG, Barentsz J, Hahn PF, et al : Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 : 2491─2499, 2003
38) Rockall AG, Sohaib SA, Harisinghani MG, et al : Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23 : 2813─2821, 2005